title: Alpha-blockers for the Treatment of Benign Prostatic Hyperplasia.
abstract: Over the last 2 decades the evolution of alpha-blockers for lower urinary tract symptoms (LUTS)/benign prostatic hyperplasia (BPH) has been to preserve effectiveness, improve tolerability, and eliminate dose titration. Today, alpha-blockers represent the first-line treatment of most men with BPH whereby the primary objective is relief from bothersome LUTS.
authors.affiliation: NYU Langone Medical Center, NYU School of Medicine, 150 East 32nd Street, 2nd Floor, New York, NY 10016, USA. Electronic address: Herbert.Lepor@nyumc.org.
authors.forename: Herbert
authors.initials: H
authors.lastname: Lepor
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D006801:Humans; D059411:Lower Urinary Tract Symptoms / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D008297:Male; D011470:Prostatic Hyperplasia / Q000150:complications / Q000188:drug therapy*; D014563:Urodynamics / Q000187:drug effects
chemical_list: D000317:Adrenergic alpha-Antagonists
keywords: Alpha-blockers; BPH; Lower urinary tract symptoms; Medical management BPH